HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parental experience of enzyme replacement therapy for Hunter syndrome.

Abstract
We aimed to establish the profile of Irish patients with Hunter Syndrome (Mucopolysaccharidosis type II, MPS II) receiving weekly intravenous Enzyme Replacement Therapy (ERT) with recombinant iduronate-2-sulfatase and to assess the social impact and parental opinion of ERT through the use of a parental questionnaire. Nine patients aged 3.5- 14 years have received a mean of 2 (range 0.5-3.5) years of ERT. Treatment was associated with clinical improvements from baseline in hepatosplenomegaly in 6/7 (85%) respiratory manifestations in 4/6 (67%) and a mean reduction in urinary glycosaminoglycan excretion of 62%. Changes noted by parents included increased energy 3/9 (33%) and softening of skin, hair and facial features 8/9 (89%). Parents report that seven hours weekly were spent on hospitalizations for ERT. Parental employment was adversely affected in 8 (89%) families. One day of school/preschool (20%) was lost every week for 8 (89%) children. All parents believed the benefits of ERT out-weigh the difficulties involved. All families would welcome the introduction of home based therapy. In conclusion the social and educational burden of hospital-based ERT on these children and their families is significant. The introduction of home-based therapy is likely to improve overall quality of life for MPSII patients and their families.
AuthorsM Buraczewska, D O'Leary, O Walsh, A Monavari, E Crushell
JournalIrish medical journal (Ir Med J) Vol. 106 Issue 4 Pg. 120-2 (Apr 2013) ISSN: 0332-3102 [Print] Ireland
PMID23691848 (Publication Type: Letter)
Chemical References
  • Iduronate Sulfatase
Topics
  • Adolescent
  • Attitude
  • Child
  • Child, Preschool
  • Enzyme Replacement Therapy
  • Female
  • Home Care Services
  • Humans
  • Iduronate Sulfatase (administration & dosage, therapeutic use)
  • Ireland
  • Male
  • Mucopolysaccharidosis II (drug therapy)
  • Parents
  • Surveys and Questionnaires
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: